Prevalence of clinically meaningful antiphospholipid antibodies in patients with systemic lupus erythematosus varies by race and ethnicity
Authors:
- 24 October 2023
- journal article
- letter
- Published by Elsevier in Annals of the Rheumatic Diseases
- Vol. 83 (3) , 404-406
Abstract
No abstract availableKeywords
Funding Information
- UCB
- Centers for Disease Control and Prevention (U01 DP005120, U01 DP006701)
- National Center for Advancing Translational Sciences of the National Institutes of Health (UL1 TR001450)
- National Institutes of Health (K24 AR068406, P30 AR072582, RO1 AR49772)
- National Institute of Arthritis and Musculoskeletal and Skin Diseases
This publication has 5 references indexed in Scilit:
- Race, Ethnicity, and Disparities in the Risk of End‐Organ Lupus Manifestations Following a Systemic Lupus Erythematosus Diagnosis in a Multiethnic CohortArthritis Care & Research, 2022
- Predictors of Pregnancy Outcomes in Patients With LupusAnnals of Internal Medicine, 2015
- International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS)Journal of Thrombosis and Haemostasis, 2006
- Epidemiology of the Antiphospholipid Antibody SyndromeJournal of Autoimmunity, 2000
- Antiphospholipid Antibodies: Anticardiolipin and the Lupus Anticoagulant in Systemic Lupus Erythematosus (SLE) and in Non-SLE DisordersAnnals of Internal Medicine, 1990